Stay updated on HSV529 Vaccine in HSV-2 Seropositive Adults Clinical Trial
Sign up to get notified when there's something new on the HSV529 Vaccine in HSV-2 Seropositive Adults Clinical Trial page.

Latest updates to the HSV529 Vaccine in HSV-2 Seropositive Adults Clinical Trial page
- Check7 days agoChange DetectedThe site revision label was updated to Revision: v3.6.6, indicating an underlying platform update. There are no changes to the displayed study details or related content.SummaryDifference0.1%

- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedPage revision label updated from v3.6.4 to v3.6.5. This indicates a minor release of the page’s content or styling, without altering the main study information.SummaryDifference0.1%

- Check42 days agoChange DetectedRevision: v3.6.4 now appears on the page, replacing the previous v3.6.3. This denotes a minor update to the ClinicalTrials.gov interface and does not modify the study content.SummaryDifference0.1%

- Check64 days agoChange DetectedThe page's revision indicator was updated from v3.6.2 to v3.6.3, indicating a minor update to the study record.SummaryDifference0.1%

- Check71 days agoChange DetectedPage revision label updated from v3.6.0 to v3.6.2, indicating a new revision of the page content. This appears to be a minor maintenance update and does not modify study data or user-facing information.SummaryDifference0.1%

- Check79 days agoChange DetectedPublications section added to the study record with a PubMed citation related to the HSV-2 vaccine research. It also notes that publications are auto-filled from PubMed and may not all pertain directly to the study.SummaryDifference0.3%

Stay in the know with updates to HSV529 Vaccine in HSV-2 Seropositive Adults Clinical Trial
Enter your email address, and we'll notify you when there's something new on the HSV529 Vaccine in HSV-2 Seropositive Adults Clinical Trial page.